Blunted Reduction in Night-time Blood Pressure is Associated with Cognitive Deterioration in Subjects with Long-standing Hypertension
Overview
Authors
Affiliations
Objective: Data about the relationship of blunted reduction of night-time blood pressure (BP) with cognitive deterioration (CD) are conflicting. This study aims to explore this possible association in elderly people with long-standing hypertension.
Methods: Twenty-six hypertensive subjects consecutively admitted to a rehabilitation unit over a six-month period were recruited. Exclusion criteria concerned all clinical conditions potentially related to BP variability or leading to CD. All patients underwent a clinic and 24-h BP non-invasive monitoring assessment of BP, as well as a cognitive assessment with the Mini Mental State Examination (MMSE). The presence of cerebrovascular disease (CVD) was assessed on CT films, with a standardized visual rating scale.
Results: Blunted reduction of both systolic and diastolic night-time BP were significantly associated with poorer cognitive performances (r=0.61, p=0.001 for systolic; and r=0.57, p=0.002 for diastolic, respectively). In a multiple regression model, blunted reduction of night-time BP (B=0.17, [95% confidence intervals: 1.1-1.3], p=0.008 for systolic; and B=0.15, [95% confidence intervals: 1.0-1.3], p=0.02 for diastolic) independently predicted poorer cognitive performances.
Conclusions: In subjects with long-standing hypertension the blunted reduction of night-time BP is independently associated with lower cognitive performances.
Evaluation of Event-Related Potentials in Somatic Diseases - Systematic Review.
Popiolek A, Niznikiewicz M, Borkowska A, Bielinski M Appl Psychophysiol Biofeedback. 2024; 49(3):331-346.
PMID: 38564137 DOI: 10.1007/s10484-024-09642-5.
Massengale K, Barnes V, Williams C, Mansuri A, Norland K, Altvater M J Clin Hypertens (Greenwich). 2024; 26(3):235-240.
PMID: 38332546 PMC: 10918738. DOI: 10.1111/jch.14764.
Angeli F, Reboldi G, Solano F, Prosciutto A, Paolini A, Zappa M Diagnostics (Basel). 2023; 13(9).
PMID: 37174992 PMC: 10178200. DOI: 10.3390/diagnostics13091601.
Gavriilaki M, Anyfanti P, Mastrogiannis K, Gavriilaki E, Lazaridis A, Kimiskidis V Aging Clin Exp Res. 2023; 35(4):745-761.
PMID: 36995461 PMC: 10115699. DOI: 10.1007/s40520-023-02361-7.
Role of angiotensin II in chronic intermittent hypoxia-induced hypertension and cognitive decline.
Marciante A, Shell B, Farmer G, Cunningham J Am J Physiol Regul Integr Comp Physiol. 2021; 320(4):R519-R525.
PMID: 33595364 PMC: 8238144. DOI: 10.1152/ajpregu.00222.2020.